Published in J Neurosci on January 12, 2011
The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature. Int J Mol Sci (2014) 1.15
The benefits and detriments of macrophages/microglia in models of multiple sclerosis. Clin Dev Immunol (2013) 1.14
Matrix metalloproteinase-9 and stromal cell-derived factor-1 act synergistically to support migration of blood-borne monocytes into the injured spinal cord. J Neurosci (2011) 1.03
Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion. Arterioscler Thromb Vasc Biol (2011) 1.02
Biologically-active laminin-111 fragment that modulates the epithelial-to-mesenchymal transition in embryonic stem cells. Proc Natl Acad Sci U S A (2014) 0.88
Understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models. Neuroimage Clin (2014) 0.88
A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis. J Neuroinflammation (2012) 0.84
Myeloid cells - targets of medication in multiple sclerosis. Nat Rev Neurol (2016) 0.83
Infiltration of CCR2+Ly6Chigh Proinflammatory Monocytes and Neutrophils into the Central Nervous System Is Modulated by Nicotinic Acetylcholine Receptors in a Model of Multiple Sclerosis. J Immunol (2016) 0.83
Neurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson's disease. World J Gastroenterol (2011) 0.82
Increased expression of EMMPRIN and VEGF in the rat brain after gamma irradiation. J Korean Med Sci (2012) 0.79
Apolipoprotein D Internalization Is a Basigin-dependent Mechanism. J Biol Chem (2015) 0.77
Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo. J Neuroinflammation (2015) 0.76
Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis. PLoS One (2015) 0.76
Enhanced expression of matrix metalloproteinase-12 contributes to Npc1 deficiency-induced axonal degeneration. Exp Neurol (2015) 0.76
Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid. PLoS One (2016) 0.75
Myeloid Kruppel-like factor 2 deficiency exacerbates neurological dysfunction and neuroinflammation in a murine model of multiple sclerosis. J Neuroimmunol (2014) 0.75
Detecting deoxyhemoglobin in spinal cord vasculature of the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis using susceptibility MRI and hyperoxygenation. PLoS One (2015) 0.75
Increased CD147 and MMP-9 expression in the normal rat brain after gamma irradiation. J Radiat Res (2012) 0.75
Local blockage of EMMPRIN impedes pressure ulcers healing in a rat model. Int J Clin Exp Pathol (2015) 0.75
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med (2002) 3.68
HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat Neurosci (2003) 2.66
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol (2005) 2.55
CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem (2002) 2.37
Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination. Ann Neurol (2012) 2.25
Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain (2002) 2.00
Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury. Brain (2012) 1.90
Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis. Am J Respir Crit Care Med (2005) 1.85
Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain (2003) 1.81
Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties. Neuro Oncol (2009) 1.80
The anchoring protein RACK1 links protein kinase Cepsilon to integrin beta chains. Requirements for adhesion and motility. J Biol Chem (2002) 1.73
Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain (2003) 1.67
A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J Neurosci (2004) 1.66
White matter plasticity and enhanced remyelination in the maternal CNS. J Neurosci (2007) 1.54
Population genetics and phylogenetic inference in bacterial molecular systematics: the roles of migration and recombination in Bradyrhizobium species cohesion and delineation. Mol Phylogenet Evol (2005) 1.51
Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology (2004) 1.49
A quantitative analysis of suspected environmental causes of MS. Can J Neurol Sci (2011) 1.47
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet (2012) 1.46
Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J Neurosci (2003) 1.45
Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry. J Neurosci Res (2008) 1.42
MMPs in the central nervous system: where the good guys go bad. Semin Cell Dev Biol (2007) 1.36
Depletion of Ly6G/Gr-1 leukocytes after spinal cord injury in mice alters wound healing and worsens neurological outcome. J Neurosci (2009) 1.35
An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J Neurosci (2003) 1.34
Vulnerability of human neurons to T cell-mediated cytotoxicity. J Immunol (2003) 1.33
Association of virulence plasmid and antibiotic resistance determinants with chromosomal multilocus genotypes in Mexican Salmonella enterica serovar Typhimurium strains. BMC Microbiol (2009) 1.28
Combination of thrombin and matrix metalloproteinase-9 exacerbates neurotoxicity in cell culture and intracerebral hemorrhage in mice. J Neurosci (2006) 1.25
Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity. Ann Neurol (2003) 1.24
Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis. Brain Res Mol Brain Res (2003) 1.18
Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction. J Leukoc Biol (2005) 1.18
An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization. FASEB J (2005) 1.18
Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. Cancer Res (2006) 1.16
Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. J Neurosci (2003) 1.15
Pathophysiology of the brain extracellular matrix: a new target for remyelination. Nat Rev Neurosci (2013) 1.15
The benefits and detriments of macrophages/microglia in models of multiple sclerosis. Clin Dev Immunol (2013) 1.14
Proteolytic processing of SDF-1alpha reveals a change in receptor specificity mediating HIV-associated neurodegeneration. Proc Natl Acad Sci U S A (2006) 1.12
A second generation of carbamate-based fatty acid amide hydrolase inhibitors with improved activity in vivo. ChemMedChem (2009) 1.11
Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. J Neurosci (2006) 1.11
Comparison of morphine, ketorolac, and their combination for postoperative pain: results from a large, randomized, double-blind trial. Anesthesiology (2005) 1.11
Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Glia (2012) 1.11
Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice. J Neurosci (2006) 1.09
Additive effect of the combination of glatiramer acetate and minocycline in a model of MS. J Neuroimmunol (2005) 1.09
Pilot study of minocycline in relapsing-remitting multiple sclerosis. Can J Neurol Sci (2008) 1.09
Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol (2004) 1.08
Remyelination therapy for multiple sclerosis. Neurotherapeutics (2013) 1.08
Peripheral nerve-derived HIV-1 is predominantly CCR5-dependent and causes neuronal degeneration and neuroinflammation. Virology (2005) 1.07
Review: Endocrine disrupting chemicals and immune responses: a focus on bisphenol-A and its potential mechanisms. Mol Immunol (2012) 1.06
Bradyrhizobium canariense sp. nov., an acid-tolerant endosymbiont that nodulates endemic genistoid legumes (Papilionoideae: Genisteae) from the Canary Islands, along with Bradyrhizobium japonicum bv. genistearum, Bradyrhizobium genospecies alpha and Bradyrhizobium genospecies beta. Int J Syst Evol Microbiol (2005) 1.06
Relative importance of proteinase-activated receptor-1 versus matrix metalloproteinases in intracerebral hemorrhage-mediated neurotoxicity in mice. Stroke (2009) 1.05
Up-regulation of proteinase-activated receptor 1 expression in astrocytes during HIV encephalitis. J Immunol (2003) 1.05
A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis. Carcinogenesis (2011) 1.05
HIV dementia patients exhibit reduced viral neutralization and increased envelope sequence diversity in blood and brain. AIDS (2002) 1.04
Contributions of multiple proteases to neurotoxicity in a mouse model of intracerebral haemorrhage. Brain (2008) 1.04
Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection. J Immunol (2005) 1.04
Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis. Brain (2009) 1.03
Increased invasive capacity of connexin43-overexpressing malignant glioma cells. J Neurosurg (2003) 1.03
Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia. Glia (2007) 1.03
Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis. Lab Invest (2003) 1.03
Toll-like receptor 2-mediated alternative activation of microglia is protective after spinal cord injury. Brain (2013) 1.03
Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate. Proc Natl Acad Sci U S A (2009) 1.02
Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod. Am J Pathol (2012) 1.02
Characterization of the early neuroinflammation after spinal cord injury in mice. J Neuropathol Exp Neurol (2007) 1.01
Molecular systematics of rhizobia based on maximum likelihood and Bayesian phylogenies inferred from rrs, atpD, recA and nifH sequences, and their use in the classification of Sesbania microsymbionts from Venezuelan wetlands. Syst Appl Microbiol (2005) 1.01
Multiexponential T2 and magnetization transfer MRI of demyelination and remyelination in murine spinal cord. Neuroimage (2009) 1.01
Cortical remyelination: a new target for repair therapies in multiple sclerosis. Ann Neurol (2012) 1.00
The many faces of EMMPRIN - roles in neuroinflammation. Biochim Biophys Acta (2010) 0.99
Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism. J Neuroinflammation (2011) 0.98
Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells. J Immunol (2009) 0.98
Overcoming neurite-inhibitory chondroitin sulfate proteoglycans in the astrocyte matrix. Glia (2013) 0.97
Analysis of the mitochondrial proteome in multiple sclerosis cortex. Biochim Biophys Acta (2011) 0.97
Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases. J Neuroimmunol (2006) 0.96
Matrix metalloproteinases in intracerebral hemorrhage. Neurol Res (2008) 0.95
Improving outcomes of neuroprotection by minocycline: guides from cell culture and intracerebral hemorrhage in mice. Am J Pathol (2010) 0.94
The Plasmodium falciparum merozoite surface protein-1 19 KD antibody response in the Peruvian Amazon predominantly targets the non-allele specific, shared sites of this antigen. Malar J (2010) 0.94
Expression and regulation of matrix metalloproteinase-12 in experimental autoimmune encephalomyelitis and by bone marrow derived macrophages in vitro. J Neuroimmunol (2008) 0.94
Immunopathogenesis of multiple sclerosis. Int Rev Neurobiol (2007) 0.94
The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase. Carcinogenesis (2005) 0.94
Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis. J Comp Neurol (2004) 0.94
Peripheral neuropathy in lentivirus infection: evidence of inflammation and axonal injury. AIDS (2004) 0.94
Continued disease activity in a patient with multiple sclerosis after allogeneic hematopoietic cell transplantation. Arch Neurol (2009) 0.93
Lentivirus infection causes neuroinflammation and neuronal injury in dorsal root ganglia: pathogenic effects of STAT-1 and inducible nitric oxide synthase. J Immunol (2005) 0.93
The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells. Carcinogenesis (2005) 0.93
Salmonella Typhimurium ST213 is associated with two types of IncA/C plasmids carrying multiple resistance determinants. BMC Microbiol (2011) 0.93
Conjugative transfer of an IncA/C plasmid-borne blaCMY-2 gene through genetic re-arrangements with an IncX1 plasmid. BMC Microbiol (2013) 0.93
Structure-property relationships of a class of carbamate-based fatty acid amide hydrolase (FAAH) inhibitors: chemical and biological stability. ChemMedChem (2009) 0.93
Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions. J Neuroimmunol (2005) 0.93
RANTES: a genetic risk marker for multiple sclerosis. Mult Scler (2004) 0.92
ADAM-10 and ADAM-17 in the inflamed human CNS. Glia (2003) 0.92
Matrix metalloproteinase-12 deficiency worsens relapsing-remitting experimental autoimmune encephalomyelitis in association with cytokine and chemokine dysregulation. Am J Pathol (2009) 0.91
Inflammatory and structural biomarkers in acute traumatic spinal cord injury. Clin Chem Lab Med (2010) 0.91
Human immunodeficiency virus type 1 envelope-mediated neuronal death: uncoupling of viral replication and neurotoxicity. J Virol (2003) 0.91
Effective combination of minocycline and interferon-beta in a model of multiple sclerosis. J Neuroimmunol (2005) 0.90
Environmental factors and their regulation of immunity in multiple sclerosis. J Neurol Sci (2012) 0.90
Magnetic resonance imaging of blood-spinal cord barrier disruption in mice with experimental autoimmune encephalomyelitis. Magn Reson Med (2007) 0.90
Migraine, headaches, and cognition. Headache (2012) 0.90
N-(2-oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships. J Med Chem (2012) 0.90